Delivery Order SPE2DB25D3012-SPE2DB25FWZNX
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,552.54 by the Defense Logistics Agency (DLA) on July 14, 2025, with an ultimate completion date of July 15, 2025. The contract calls for the delivery of Clobazam 10 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,622.52 on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,667.79 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Clobazam 10 mg tablets (100-count) valued at $2,214.14. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,637.91 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1.84K to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) with a completion date of July 1, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.99 to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, with a completion date of March 6, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,750.23 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $3,602.82 and is structured as a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZNXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,390.75 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance, which notably aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its comprehensive prime vendor agreement to supply critical medications across multiple therapeutic domains to support military and federal healthcare systems. The Clobazam delivery exemplifies the company's role in fulfilling specialized pharmaceutical requirements for the Defense Health Agency and other government healthcare customers. AmerisourceBergen's extensive federal contract portfolio and substantial IDC vehicle demonstrate its capacity to meet the Department of Defense's pharmaceutical supply chain needs, positioning it as a critical vendor for military medical readiness and veteran healthcare support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/26/25 |